Trial intelligence / Profile preview

Bioequivalence Study of Two 1 mg Entecavir Film-coated Tablet Formulations in Healthy Thai Volunteers under Fasting

TCTR20190116002Phase 4Not yet recruiting

Sponsor
Daewoong Pharmaceutical
Start
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of entecavir in hepatitis B (HBV), sponsored by Daewoong Pharmaceutical. Planned start May 2019; status: not yet recruiting.

02

Drugs

entecavir
03

Conditions

hepatitis B (HBV)

Beyond the preview

Go deeper on TCTR20190116002.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20190116002.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call